United Therapeutics Corp.
United Therapeutics, a biotech focused on pulmonary arterial hypertension and neuroblastoma, generates revenue from Tyvaso, Remodulin, Orenitram, Adcirca and Unituxin, with an expanding pipeline and strategic partnerships with DEKA, MannKind, and Arena.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 1,305
- HQ: Silver Spring
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.